# OnCo record paper-zeta-vandetanib-mtc-wells-jco-2012 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-zeta-vandetanib-mtc-wells-jco-2012/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-zeta-vandetanib-mtc-wells-jco-2012" ;
  schema:name "ZETA: vandetanib in locally advanced or metastatic medullary thyroid cancer"@en ;
  schema:description "Vandetanib was the first drug shown to delay progression in medullary thyroid cancer, roughly doubling progression-free survival compared with placebo, and became the first approved therapy for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-zeta-vandetanib-mtc-wells-jco-2012/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2011.35.5040>, <https://pubmed.ncbi.nlm.nih.gov/22025146/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2011.35.5040> ;
  schema:datePublished "2012"^^xsd:gYear ;
  schema:author "Wells SA, Robinson BG, Gagel RF, et al." ;
  onco:cancers <https://onco.cc/cancers/medullary-thyroid-cancer/> ;
  onco:drugs <https://onco.cc/drugs/vandetanib/> ;
  onco:trials <https://onco.cc/trials/zeta/> ;
  onco:journals <https://onco.cc/journals/jco/> .